arrow
B

Brett Doble

iqvia
H指数:22
被引数:1,435

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL

评估外部证据在生存外推中的应用角色与政策启示:一项关于Axicabtagene Ciloleucel疗法在二线DLBCL中应用的案例研究

2025-08-070
OAAI
Estimating the Impact on Survival of Not Receiving CAR T Therapy Despite Being Eligible in Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Patients in Germany

评估在德国复发或难治性(R/R)弥漫性大B细胞淋巴瘤(DLBCL)患者中,尽管符合条件但未接受CAR T疗法对生存的影响

BLOOD
IF23.1
2024-11-050
PRE
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies
2023-05-014
OA